Angiotensinogen and HLA class II predict bevacizumab response in recurrent glioblastoma patients
Titel:
Angiotensinogen and HLA class II predict bevacizumab response in recurrent glioblastoma patients
Auteur:
Urup, Thomas Michaelsen, Signe Regner Olsen, Lars Rønn Toft, Anders Christensen, Ib Jarle Grunnet, Kirsten Winther, Ole Broholm, Helle Kosteljanetz, Michael Issazadeh-Navikas, Shohreh Poulsen, Hans Skovgaard Lassen, Ulrik